PROSPECTUS SUPPLEMENT Filed pursuant to Rule 424(b)(3)
To Prospectus Dated July 31, 1997, Registration No. 333-31973
As Supplemented to Date
1,657,560 Shares
PHYMATRIX CORP.
Common Stock
This Prospectus Supplement (the "Supplement") relates to up to 18,064
shares (the "Shares") of Common Stock, par value $.01 per share, of PhyMatrix
Corp., a Delaware corporation (the "Company"), which may be offered and sold by
Atlanta Metro Urology, P.A. (the "Selling Stockholder") pursuant to the
Company's Registration Statement on Form S-3 (No. 333-31973) (the "Registration
Statement"). This Supplement should be read in conjunction with the Prospectus
dated July 31, 1997, which is a part of the Registration Statement, as such
Prospectus may have been supplemented to date (the "Prospectus"). A copy of the
Prospectus accompanies this Supplement. All capitalized terms used but not
defined in this Supplement shall have the meanings given them in the Prospectus.
The Shares were acquired by the Selling Stockholder under the terms of the
Company's acquisition on July 3, 1997 of the assets of the Selling Stockholder.
To the Company's knowledge, the Shares which may be offered represent all the
shares of Common Stock currently owned by the Selling Stockholder. If all of
such Shares are sold, the Selling Stockholder will not hold any shares of Common
Stock of the Company.
The closing price of the Company's Common Stock as reported on The Nasdaq
National Market on August 26, 1997 was $12.5625 per share.
The date of this Prospectus Supplement is August 27, 1997.
